Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
An insoluble polysaccharide from the sclerotium of poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota
(River Peptides) Thus FOXO4-DRI belongs to the next generation of senolytic tools with improved selectivity and lower collateral damage risk (at least in preclinical models)
The study analyzed data from about 1,900 people taking semaglutide and 1,350 people taking Contrave, a weight loss medication that works differently from GLP-1 drugs
Watlington Riley and Wendy Waugh George Weinhouse Partner ($1,0001,499) Howard and Penny Aldrich Marie and Michael Andreasen Shulamit L
US$ 25.04
US$ 24.41
US$ 27.42
US$ 21.03
US$ 25.17
US$ 25.96
US$ 20.52
US$ 27.71
US$ 22.44
US$ 26.28
US$ 26.19
US$ 23.43
US$ 24.84
